Optionale Produktanalyse
Mit Ihrer Erlaubnis verwenden wir datenschutzfreundliche Analysen, um zu verstehen, welche Recherchewege funktionieren. Wir verwenden weder Werbe-Tracker noch Sitzungsaufzeichnungen. Sie können diese Auswahl in den Einstellungen ändern. Lesen Sie die Datenschutzerklärung.
3M Company's published Sell conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $87.4B |
|---|
| Revenue (ttm) | 25.2B |
|---|
| Net income (ttm) | 3.5B |
|---|
| EPS (ttm) | $6.68 |
|---|
| Shares out | 516.7M |
|---|
| P/E (trailing) | 25.9x |
|---|
| P/E (forward) | 17.8x |
|---|
| Dividend | $3.12 (1.81%) |
|---|
| Volume | 2,164,028 |
|---|
| Beta | 1.06 |
|---|
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | Trend |
| Revenue | $35.36B | $26.16B | $24.61B | $24.58B | $24.95B | -8.3% |
| Gross profit | $16.61B | $14.97B | $14.20B | $10.08B | $9.87B | -12.2% |
| Operating income | $7.37B | $4.37B | $-10.69B | $4.82B | $4.63B | -11.0% |
| Net income | $5.92B | $5.78B | $-7.00B | $4.17B | $3.25B | -13.9% |
| EPS (diluted) | $10.12 | $10.18 | $-12.63 | $7.55 | $6.00 | -12.3% |
| EBITDA | $9.58B | $8.72B | $-9.13B | $7.23B | $5.85B | -11.6% |
| R&D | $1.20B | $800.0M | $700.0M | $700.0M | $1.17B | -0.7% |
| SG&A | $7.20B | $7.23B | $19.20B | $4.22B | $4.00B | -13.7% |
Recent company headlines from major financial publishers.
In the base case, 3M executes its turnaround plan following the Solventum healthcare spin-off. Operating margins expand from 18.55% in FY2025 to 19.37% in FY2026 and 20.38% in FY2027, reaching 21.42% by FY2030. The core Safety & Industrial business provides steady profitability ($2,836M EBIT in FY2025), while Transportation & Electronics benefits from gradual optical growth. However, because $8.6B of the $10B+ capital return authorization has already been executed, buyback support tapers sharply, resulting in post-FY2027 EPS growth slowing to -2.28% in FY2028 and -3.38% in FY2029.
In the upside scenario, operational restructuring accelerates operating margins beyond 25% by 2027 ahead of guidance. 3M's Expanded Beam Optics platform establishes standard interconnect architecture across 44 hyperscaler and semiconductor ecosystem partners, scaling toward a $2B addressable market by 2028. Robust free cash generation supports over $10B in capital returns, driving 11.5% EPS CAGR and multiple expansion toward peer median of 19.5x.
| Ke ↓ / g → | 2.0% | 2.3% | 2.5% | 2.8% | 3.0% |
|---|---|---|---|---|---|
| 8.3% | $112 | $113 | $114 | $116 | $117 |
| 8.8% | $108 | $109 | $110 | $112 | $113 |
| 9.3% | $105 | $106 | $107 | $108 | $109 |
| 9.8% | $103 | $103 | $104 | $105 | $106 |
| 10.3% | $100 | $101 | $102 | $102 | $103 |
Upcoming earnings date and setup when available.
Das Rating, das die veröffentlichte Research-Ausgabe des jeweiligen Monats trug. Ein Rating vergleicht den Kurs zum Analysezeitpunkt mit dem Fair Value; es ist kein Nachweis, ob die Einschätzung zutraf.
| Jahr | Jan | Feb | Mär | Apr | Mai | Jun | Jul | Aug | Sep | Okt | Nov | Dez |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |
